Study sheds light on weight regain after GLP-1 discontinuation
A sizable percentage of people using Novo (NVO) and Lilly’s (LLY) GLP-1 drugs may be able to sustain their weight loss...
Tag: LLY
Abivax CEO responds to Lilly acquisition rumors
Commenting on reports that Eli Lilly (LLY) has approached the French government to acquire Abivax (ABVX), Marc de Garidel,...
Key deals this week: Micron Technology, Worthington Steel, Boston Scientific, CrowdStrike and more
Here's a list of key deals reported across sectors this week: Micron Technology (MU) on Saturday announced plans to acquire...
Eli Lilly drops as FDA decision on weight loss pill is now expected in April
Eli Lilly (LLY) shares slipped ~5% on Thursday, marking what could be its biggest intraday loss in five months after Reuters...
Disc Medicine and Sanofi reportedly face delays for FDA national priority review vouchers
Two drugs developed by Disc Medicine (IRON) and Sanofi (SNY) are facing delays in their review timelines due to safety and...
Compounding pharmacy sues Lilly, Novo over GLP-1 drug competition
Arizona-based Strive Compounding Pharmacy has sued Eli Lilly (LLY) and Novo Nordisk (NVO) in a Texas federal court alleging...
FDA asks Lilly, Novo to remove suicide warning related to GLP-1 obesity drugs
The U.S. FDA on Tuesday requested Novo Nordisk (NVO) and Eli Lilly (LLY) to implement labeling changes for their blockbuster...
Novo Nordisk CEO says up to 1.5M Americans are on compounded GLP-1s
Novo Nordisk (NVO) CEO Mike Doustdar says that up to 1.5M patients in the U.S. could be using compounded versions of GLP-1...
4 stocks to watch on Tuesday: JPM, LLY, USB, PANW
Stock index futures rose on Tuesday as core CPI inflation came in slightly cooler than expected. Here are the four stocks to...
Eli Lilly CFO says obesity pill on track for FDA nod in Q2
In an interview with Bloomberg News, Eli Lilly Chief Financial Officer Lucas Montarce said that the Indiana-based pharma...